Chronicle Journal: Finance

J&J's one-shot Covid vaccine is safe and generates promising immune response in early trial

The new clinical trial data shows a single shot of the vaccine "gives sustainable antibodies," Dr. Paul Stoffels, J&J chief scientific officer, told CNBC.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.